Position in EDIT
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$1,379,684
-$428,333 QoQ
Shares Held
558,577
-36.7% QoQ
Ownership
0.571%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 99.13261734729501.ToString("F0")%
Shared 0.ToString("F0")%
None 0.8673826527049986.ToString("F0")%
Common Shares in EDIT Over Time
Shares Held
Position Value (USD)
Derivatives in EDIT
reported options exposure · as of Sep 30, 2021CallValue
$0
CallShares
0
PutValue
$295,776
PutShares
7,200
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026GOLDMAN SACHS GROUP INC holds $10,294,260,512 across 365 Biotechnology names. EDIT ranks #242 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,417,875 | $1,079,677,898 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,300,558 | $1,004,863,129 | |
| 3 | MRNA |
Moderna, Inc.
|
6,603,697 | $335,467,805 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
11,111,591 | $307,791,069 | |
| 5 | PRAX |
Praxis Precision Medicines, Inc.
|
710,734 | $228,991,385 | |
| 6 | INCY |
Incyte Corp
|
2,351,221 | $221,296,919 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
2,185,500 | $212,539,874 | |
| 8 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
1,965,432 | $170,933,620 |
All Filings in EDIT
Export CSV
28 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,379,684 | 558,577 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $1,808,017 | 881,960 | Shares | Defined | 2026-03-25 | |
| 2025-09-30 | $1,590,217 | 458,276 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $1,449,188 | 658,722 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $658,304 | 567,504 | Shares | Defined | 2025-06-27 | |
| 2024-12-31 | $2,268,479 | 1,786,205 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $3,980,130 | 1,167,194 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $5,691,267 | 1,218,687 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $10,394,914 | 1,400,932 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $5,612,768 | 554,074 | Shares | Defined | 2024-05-14 | |
| 2023-09-30 | $3,472,084 | 445,139 | Shares | Defined | 2024-05-15 | |
| 2023-06-30 | $4,955,973 | 602,184 | Shares | Defined | 2024-05-14 | |
| 2023-03-31 | $5,118,905 | 706,056 | Shares | Defined | 2024-05-14 | |
| 2022-12-31 | $8,002,060 | 902,149 | Shares | Defined | 2024-05-14 | |
| 2022-09-30 | $13,656,449 | 1,115,723 | Shares | Defined | 2024-05-14 | |
| 2022-06-30 | $9,318,726 | 787,720 | Shares | Defined | 2024-05-14 | |
| 2022-03-31 | $12,088,141 | 635,549 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $26,155,838 | 985,154 | Shares | Defined | 2022-02-17 | |
| 2021-09-30 | $56,954,503 | 1,386,429 | Shares | Defined | 2022-01-20 | |
| 2021-09-30 | $295,776 | 7,200 | Put | Defined | 2022-01-20 | |
| 2021-06-30 | $45,499,647 | 803,313 | Shares | Defined | 2021-08-13 | |
| 2021-06-30 | $407,808 | 7,200 | Put | Defined | 2021-08-13 | |
| 2021-03-31 | $38,135,118 | 907,979 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $71,771,045 | 1,023,692 | Shares | Defined | 2021-02-12 | |
| 2020-12-31 | $350,550 | 5,000 | Put | Defined | 2021-02-12 | |
| 2020-09-30 | $27,766,996 | 989,558 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $22,867,854 | 773,085 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $13,076,060 | 659,408 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||